Santa Clara, California - The U.S. Food and Drug Administration today approved the first fully absorbable stent to treat coronary artery disease. The Absorb GT1 Bioresorbable Vascular Scaffold System (BVS), which releases the drug everolimus to limit the growth of scar tissue, is gradually absorbed by the body in approximately three years.

Ann Arbor, Michigan - Free radicals cause cell damage and death, aging and disease, and scientists have sought new ways to repel them for years.

Dallas, Texas - About one in every nine men will experience sudden cardiac death, most before age 70, as well as about one in 30 women, according to research published in the Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.

Washington, DC - The U.S. Food and Drug Administration issued a proposed rule requesting additional scientific data to support the safety and effectiveness of certain active ingredients used in topical consumer antiseptic rubs (including hand sanitizers) marketed over-the-counter (OTC). The FDA’s request for more data is intended to help the agency ensure that regular use of these products does not present unknown safety and efficacy concerns, and does not mean the FDA believes these products are ineffective or unsafe.

Atlanta, Georgia - Living a healthy lifestyle can help reduce your risk of colorectal cancer, but regular screening is also important. Testing can often find colorectal cancer early, when it’s most treatable, or sometimes even prevent it altogether. For that reason, the American Cancer Society and the Anthem Foundation are working together to encourage all men and women to get screened beginning at age 50. And together their efforts to increase awareness are already helping remove barriers.

Rochester, Minnesota - Early Alzheimer's disease and depression share many symptoms, so it can be hard - even for doctors - to distinguish between the disorders. Plus, many people with Alzheimer's disease also are depressed.